Amdocs (NASDAQ:DOX) Issues Q4 2026 Earnings Guidance

Amdocs (NASDAQ:DOX) issued an update on its fourth quarter 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 1.940-2.000 for the period, compared to the consensus earnings per share estimate of 1.940. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. Amdocs also updated its FY 2026 guidance to 7.374-7.444 EPS.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Cfra downgraded shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a report on Wednesday. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a research report on Sunday, July 5th. KeyCorp initiated coverage on Amdocs in a research report on Monday, June 29th. They set a “sector weight” rating on the stock. Finally, Stifel Nicolaus decreased their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Amdocs currently has a consensus rating of “Hold” and an average price target of $86.67.

Amdocs Price Performance

Shares of DOX opened at $59.12 on Friday. Amdocs has a one year low of $49.74 and a one year high of $90.29. The stock’s fifty day moving average is $54.49 and its 200-day moving average is $63.33. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.98 and a current ratio of 0.98. The firm has a market capitalization of $6.38 billion, a price-to-earnings ratio of 14.08, a price-to-earnings-growth ratio of 0.96 and a beta of 0.40.

Amdocs (NASDAQ:DOX) last announced its earnings results on Wednesday, August 5th. The technology company reported $1.84 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.84. The firm had revenue of $1.17 billion during the quarter, compared to analyst estimates of $1.18 billion. Amdocs had a net margin of 9.75% and a return on equity of 20.10%. Amdocs’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.72 EPS. Amdocs has set its Q4 2026 guidance at 1.940-2.000 EPS and its FY 2026 guidance at 7.374-7.444 EPS. Equities analysts anticipate that Amdocs will post 6.56 EPS for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date is Wednesday, September 30th. Amdocs’s dividend payout ratio (DPR) is currently 54.05%.

Institutional Investors Weigh In On Amdocs

Hedge funds and other institutional investors have recently bought and sold shares of the business. Alyeska Investment Group L.P. raised its stake in Amdocs by 155.1% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,110,393 shares of the technology company’s stock valued at $169,908,000 after purchasing an additional 1,283,231 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Amdocs by 24.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,892,761 shares of the technology company’s stock worth $232,903,000 after buying an additional 560,380 shares during the period. Squarepoint Ops LLC grew its holdings in shares of Amdocs by 469.4% during the fourth quarter. Squarepoint Ops LLC now owns 543,875 shares of the technology company’s stock valued at $43,787,000 after buying an additional 448,358 shares in the last quarter. Voloridge Investment Management LLC grew its holdings in shares of Amdocs by 501.1% during the fourth quarter. Voloridge Investment Management LLC now owns 520,494 shares of the technology company’s stock valued at $41,905,000 after buying an additional 433,907 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in Amdocs by 50.8% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,004,757 shares of the technology company’s stock valued at $80,893,000 after buying an additional 338,408 shares during the period. 92.02% of the stock is currently owned by institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.